Atropine - Revision history

Danbot: add References section

2026-03-22T08:46:50Z

add References section

← Older revision		Revision as of 08:46, 22 March 2026
Line 94:		Line 94:
	*[[Anticholinergic toxicity]]		*[[Anticholinergic toxicity]]

	[[Category:Pharmacology]] [[Category:Cardiology]] [[Category:Toxicology]]		[[Category:Pharmacology]] [[Category:Cardiology]]
			==References==
			<references/>

			[[Category:Toxicology]]

2026-03-20T21:55:12Z

Switch SMW query from broadtable to table format for better layout with TOC

2026-03-20T17:23:49Z

Fix SMW query: replace link=subject with mainlabel=- to fix broken subobject fragment links

2026-03-20T16:41:57Z

Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template)

@@ Line 71: / Line 71: @@
 *Parasympatholytic
 **Increases sinus/AV conduction
 ==See Also==

2019-09-19T20:18:08Z

← Older revision		Revision as of 20:18, 19 September 2019
Line 77:		Line 77:
	*[[Anticholinergic toxicity]]		*[[Anticholinergic toxicity]]

	[[Category:Pharmacology]]		[[Category:Pharmacology]] [[Category:Cardiology]] [[Category:Toxicology]]

2018-02-27T14:08:37Z

Adverse Reactions

← Older revision		Revision as of 14:08, 27 February 2018
Line 49:		Line 49:
	==Adverse Reactions==		==Adverse Reactions==
	===Serious===		===Serious===
	*Cardiac dysrhythmia, tachyarrhythmia		*[[Cardiac dysrhythmia]], [[tachyarrhythmia]]
	*If given slowly or in amounts <0.5mg, may cause paradoxical bradycardia		*If given slowly or in amounts <0.5mg, may cause paradoxical bradycardia
	*Increased O2 consumption		*Increased O2 consumption
	*Hypotension		*[[Hypotension]]
	*Coma		*[[Coma]]
	*Respiratory depression		*Respiratory depression
	*Glaucoma		*[[Glaucoma]]

	===Common===		===Common===
	*Constipation, xerostomia		*Constipation, xerostomia

2018-02-27T14:08:07Z

Pediatric dosing

← Older revision		Revision as of 14:08, 27 February 2018
Line 21:		Line 21:

	==Pediatric dosing==		==Pediatric dosing==
	*Symptomatic bradyarrhythmia or AV block: 0.01-0.03 mg/kg IV/IO q1-2h		===[[Symptomatic bradyarrhythmia]] or [[AV block]]===
	*Cardiac arrest (bradyasystolic): 0.01-0.03 mg/kg IV/IM/subQ/endotracheally		*0.01-0.03 mg/kg IV/IO q1-2h
	*Organophosphate toxicity: 0.01-0.03 mg/kg IV/IM/subQ/endotracheally
	*IBS, PUD: 0.01 mg/kg (max 0.4 mg or 0.3 mg/m2) PO/SC q4-6h		===[[Cardiac arrest]] (bradyasystolic)===
	*Cycloplegia/mydriasis induction: 1-2 drops of 1% solution 1-3 times daily		*0.01-0.03 mg/kg IV/IM/subQ/endotracheally

			===[[Organophosphate toxicity]]===
			*0.01-0.03 mg/kg IV/IM/subQ/endotracheally

			===[[IBS]], [[PUD]]===
			*0.01 mg/kg (max 0.4 mg or 0.3 mg/m2) PO/SC q4-6h

			===Cycloplegia/mydriasis induction===
			*1-2 drops of 1% solution 1-3 times daily

	==Special Populations==		==Special Populations==

2018-02-27T14:06:38Z

Adult Dosing

← Older revision		Revision as of 14:06, 27 February 2018
Line 5:		Line 5:

	==Adult Dosing==		==Adult Dosing==
	*Symptomatic bradyarrhythmia or AV block~~, :~~ 0.5 mg IV rapid push q3-5m (max = 0.04 milligram/kg)		===[[Symptomatic bradyarrhythmia]] or [[AV block]]===
	*Cardiac arrest (bradyasystolic): 1mg IV/IM/subQ/endotracheally q3-5m		*0.5 mg IV rapid push q3-5m (max = 0.04 milligram/kg)
	*Organophosphate toxicity: 1-3mg IV/IM/SC/endotracheally q10-30m, max 3 doses
	*IBS, PUD: 0.4-0.6 mg PO or IV/IM/SC q4-6h		===[[Cardiac arrest]] (bradyasystolic)===
	*Cycloplegia/mydriasis induction: 1-2 drops of 1% solution 1-3 times daily		*1mg IV/IM/subQ/endotracheally q3-5m

			===[[Organophosphate toxicity]]===
			*1-3mg IV/IM/SC/endotracheally q10-30m, max 3 doses

			===[[IBS]], [[PUD]]===
			*0.4-0.6 mg PO or IV/IM/SC q4-6h

			===Cycloplegia/mydriasis induction===
			*1-2 drops of 1% solution 1-3 times daily

	==Pediatric dosing==		==Pediatric dosing==

2018-02-27T14:05:12Z

Mechanism of Action

← Older revision		Revision as of 14:05, 27 February 2018
Line 52:		Line 52:
	*Parasympatholytic		*Parasympatholytic
	**Increases sinus/AV conduction		**Increases sinus/AV conduction


	==See Also==		==See Also==

2018-02-21T16:11:27Z

Special Populations

← Older revision		Revision as of 16:11, 21 February 2018
Line 23:		Line 23:
	*Renal Dosing: no adjustment		*Renal Dosing: no adjustment
	*Hepatic Dosing: no adjustment		*Hepatic Dosing: no adjustment
			*Ineffective in cardiac transplant patients

	==Contraindications==		==Contraindications==